Unimark Remedies Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LISINOPRIL USP, with a corresponding US DMF Number 17626.
Remarkably, this DMF maintains an Active status since its submission on August 26, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 10, 2013, and payment made on March 13, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II